Greek sinusitis study aims to personalize treatment by analyzing inflammation
NCT ID NCT07663409
First seen Jun 25, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study will collect and analyze nasal tissue from 230 Greek patients with chronic sinusitis (with or without nasal polyps) to identify different inflammation patterns, called endotypes. By understanding these patterns, researchers hope to better match patients with the most effective biologic treatments. The study is observational and does not test any new drug or intervention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose more personalized treatments for chronic sinusitis patients based on their specific inflammation type.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to non-Greek populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGAlexandroupoli, Greece
-
Research Site
NOT_YET_RECRUITINGAthens, Greece
-
Research Site
NOT_YET_RECRUITINGHeraklion, Greece
-
Research Site
NOT_YET_RECRUITINGThessaloniki, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug that calms inflammation ease chronic sinusitis?
- Triple-Action nasal spray could ease chronic sinusitis
- 3D-Printed nose models could boost sinus rinse results
- New study digs into how mepolizumab changes nose bacteria and genes in asthma patients
- New pill aims to ease stuffy nose and facial pain for sinusitis sufferers
- New hope for sinus sufferers: drug targets stubborn inflammation